Answers are grounded in this paper and cite their sources.
Axial myopia is a major cause of vision impairment globally, driven in part by extracellular matrix remodeling in the sclera. However, the limited availability of tools for sclera-directed gene delivery limits mechanistic studies. To address this gap, we compared the transduction profiles of vectors packaged in eight adeno-associated virus (AAV) capsid variants in the sclera and extraocular muscles (EOM) following sub-Tenon injection. These vectors comprised seven natural serotypes (AAV1, AAV2, AAV5, AAV6, AAV7, AAV8, and AAV9) and the engineered chimeric capsid AAV-DJ, each carrying green fluorescent protein (GFP) under the control of the Cytomegalovirus early enhancer/chicken β-actin hybrid promoter (CAG) promoter, and were administered to C57BL/6J mice via sub-Tenon injection ( n = 4 mice per group). Four weeks later, GFP expression was assessed using whole-mount fluorescence imaging and Western blotting of the sclera and EOM. Among all tested serotypes, AAV7 showed the highest mean whole-mount scleral fluorescence, AAV1 showed the highest mean normalized scleral GFP signal by Western blotting, and AAV8 showed a visually more even fluorescence pattern in the representative whole-mount images and the highest group-level sclera-to-EOM proxy ratio. However, this ratio was calculated from differently normalized measurements and was therefore interpreted only as a descriptive proxy rather than a direct quantitative comparison between the two tissues. These findings indicate that the tested AAV serotypes have different transduction profiles under the conditions examined and provide comparative information for the selection and further evaluation of candidate serotypes for scleral gene delivery.
No takes yet. Share an insight, caveat, or question.
栗本 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: